AL
ZTS icon

Aspiriant LLC’s Zoetis ZTS Stock Holding History

Aspiriant LLC’s Portfolio ZTS Stock Details ZTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,213
Closed -$374K – 329
2024
Q1 		$374K Buy
2,213
+456
+26% +$85.4K 0.02% 226
2023
Q4 		$347K Buy
+1,757
New +$311K 0.02% 226
2023
Q3 		– Sell
-1,177
Closed -$203K – 298
2023
Q2 		$203K Buy
+1,177
New +$203K 0.01% 272

Other funds holding ZTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Aspiriant LLC's ZTS Position: Q2 2024 in Review

Aspiriant LLC sold out of Zoetis (ZTS) in Q2 2024, closing a stake of 2,213 shares — an estimated $374K sold.

Aspiriant LLC first reported a position in ZTS in Q2 2023 and held it in 3 quarters. The position peaked at $374K in Q1 2024. 1,739 funds tracked by Wall St. Rank hold ZTS as of Q2 2024.

  • Aspiriant LLC reported no remaining Zoetis position as of Q2 2024 after selling out during the quarter.
  • Aspiriant LLC sold 2,213 Zoetis shares in Q2 2024, an estimated $374K.
  • Aspiriant LLC first reported a position in Zoetis in Q2 2023 and held it in 3 quarters.
  • Aspiriant LLC's Zoetis position peaked at $374K in Q1 2024.
  • 1,739 funds tracked by Wall St. Rank held Zoetis as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.